Header Logo

Connection

Johnny Mahlangu to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Johnny Mahlangu has written about Clinical Trials, Phase III as Topic.
Johnny Mahlangu
Connection Strength
0,158
Clinical Trials, Phase III as Topic
  1. Bispecific Antibody Emicizumab for Haemophilia A: A Breakthrough for Patients with Inhibitors. BioDrugs. 2018 Dec; 32(6):561-570.
    View in: PubMed
    Score: 0,158
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.